The relationship of plasma aluminum to oxidant-antioxidant and inflammation status in asthma patients

被引:9
|
作者
Guo, Chih-Hung [1 ]
Chen, Pei-Chung [1 ]
Hsia, Simon [1 ]
Hsu, Guoo-Shyng W. [2 ]
Liu, Po-Jen [1 ,3 ,4 ]
机构
[1] Hung Kuang Univ, Inst Biomed Nutr, Micronutr Lab, Taichung 433, Taiwan
[2] Fu Jen Catholic Univ, Dept Nutr Sci, Taipei 242, Taiwan
[3] Cheng Ching Hosp, Dept Otolaryngol, Taichung 407, Taiwan
[4] Cheng Ching Hosp, Nutr & Naturopath Ctr, Taichung 407, Taiwan
关键词
Aluminum; Asthma; Oxidative stress; Inflammation; NECROSIS-FACTOR-ALPHA; TOTAL SERUM IGE; OXIDATIVE STRESS; AIRWAY INFLAMMATION; GENE-EXPRESSION; TH2; CYTOKINES; CELLS; HYPERRESPONSIVENESS; INTERLEUKIN-10; SENSITIZATION;
D O I
10.1016/j.etap.2012.10.005
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Aluminlim (Al) is a non-essential mineral which human beings are exposed to on day-today life. The purpose of this study was to assess the concentrations of plasma Al and the relationship of those levels with risk factors for asthma. In total, 27 allergic asthmatics and 30 healthy volunteers were enrolled. Plasma Al and selected blood parameters were measured, and a pulmonary function test was performed. Higher Al concentrations were found in the asthmatics than the healthy controls. Increased immunoglobulin E, high-sensitivity C-reactive protein, lipid peroxidation products, and pro-inflammatory cytokines (tumor necrosis factor-a and interleukin [IL]-4) were observed, but IL-10 and overall antioxidant and enzyme activities were lower. Associations between oxidative-antioxidant status and inflammatory markers with plasma Al levels in asthmatics were noted. Al status was also linked to cytokine concentrations and pulmonary function. In conclusion, abnormal Al distribution may further precipitate oxidative stress and inflammation, alter Th1/Th2 lymphocyte balance, and therefore contribute to the development of asthma. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [31] Role of altered level of oxidant-antioxidant in disease prognosis of asthma
    Ahmad, Asrar
    Shameem, Mohammad
    Husain, Qayyum
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [32] Oxidant-antioxidant profiles of platelet rich plasma in smokers
    Gökkusu, C
    Ademoglu, E
    Tamer, S
    Alkan, G
    [J]. ADDICTION BIOLOGY, 2001, 6 (04) : 325 - 330
  • [33] OXIDANT-ANTIOXIDANT SYSTEM IN PATIENTS WITH MULTIPLE MYELOMA
    Aleksanian, L.
    Rybakova, L.
    Kapustin, S.
    Gritsaev, S.
    Bessmeltsev, S.
    [J]. HAEMATOLOGICA, 2017, 102 : 639 - 639
  • [34] The Oxidant-Antioxidant Balance in Mild Asthmatic Patients
    I. Hanta
    S. Kuleci
    N. Canacankatan
    A. Kocabas
    [J]. Lung, 2003, 181 : 347 - 352
  • [35] The oxidant-antioxidant balance in mild asthmatic patients
    Hanta, I
    Kuleci, S
    Canacankatan, N
    Kocabas, A
    [J]. LUNG, 2003, 181 (06) : 347 - 352
  • [36] OXIDANT-ANTIOXIDANT STATUS IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    DROGE, W
    ECK, HP
    MIHM, S
    [J]. OXYGEN RADICALS IN BIOLOGICAL SYSTEMS, PT C, 1994, 233 : 594 - 601
  • [37] Unbalanced oxidant-antioxidant status and its effects in pediatric diseases
    Chiavaroli, Valentina
    Giannini, Cosimo
    De Marco, Stefania
    Chiarelli, Francesco
    Mohn, Angelika
    [J]. REDOX REPORT, 2011, 16 (03) : 101 - 107
  • [38] Effects of shearing procedures on oxidant-antioxidant status in Chios sheep
    Fidan, A. F.
    Kucukkurt, I.
    Eryavuz, A.
    Cigerci, I. H.
    Yardimci, M.
    Ozdemir, A.
    [J]. REVUE DE MEDECINE VETERINAIRE, 2009, 160 (07) : 349 - 355
  • [39] Study of oxidant-antioxidant status in cerebrospinal fluid of children with meningitis
    Sarhat, Entedhar R.
    Al Anzy, Moayad M.
    Ahmed, Takea Shaker
    [J]. EURASIAN CHEMICAL COMMUNICATIONS, 2022, 4 (09): : 863 - 869
  • [40] Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant-antioxidant status
    Selek, Salih
    Herken, Hasan
    Bulut, Mahmut
    Ceylan, Mehmet F.
    Celik, Hakim
    Savas, Haluk A.
    Erel, Ozcan
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 487 - 491